New DNA Test for Inflammation and Aging
Author Information
Author(s): Meier Helen, Klopack Eric, Farina Mateo, Hernández Belinda, Mitchell Colter, Faul Jessica, McCrory Cathal, Crimmins Eileen
Primary Institution: Institute for Social Research, Michigan, United States
Hypothesis
Can a DNA methylation-based biomarker effectively predict chronic systemic inflammation and its associated health outcomes?
Conclusion
The InfLaMeS biomarker is a strong alternative to traditional blood tests for measuring inflammation and predicting health outcomes.
Supporting Evidence
- The InfLaMeS biomarker correlates strongly with individual inflammation markers.
- It performs similarly to traditional measures of systemic inflammation.
- The study focused on predicting multimorbidity, disability, and mortality.
Takeaway
Scientists created a new DNA test that can help us understand how inflammation affects our health as we age.
Methodology
The study evaluated a DNA methylation surrogate biomarker against measured inflammatory biomarkers in predicting health outcomes.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website